Please login to the form below

Not currently logged in
Email:
Password:

Pascale Richetta moves from AbbVie to UCB

She joins the biopharmaceutical company as executive vice president
Pascale Richetta

UCB has appointed Pascale Richetta to lead the global biopharmaceutical company's new bone patient value unit with effect from 1 February.

The unit was created last year with the development of UCB's patient value organisation and is currently led by its chief medical officer and head of the development of medical practices Iris Loew Friedrich.

In her new role Richetta will also serve at UCB as an executive vice president and member of the Belgium-based company's executive committee.

She has over 20 years of commercial and managerial experience in the pharmaceutical industry having worked with both traditional pharmaceuticals and complex biologics.

Richetta most recently served as vice president for Western Europe and Canada for AbbVie.

Prior to this, Richetta held managerial positions at Abbott, GSK, Ipsen and Servier where she was responsible for the international launch of each company's key drugs.

21st January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics